ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pentavalent Antimonials Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-13W853
Home | Market Reports | Health| Pharmacy
Global Pentavalent Antimonials Market Insights Forecast to 2028
BUY CHAPTERS

Global Pentavalent Antimonials Market Insights, Forecast to 2030

Code: QYRE-Auto-13W853
Report
December 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
GlaxoSmithKline PLC
Bristol–Myers Squibb
Maiden Pharmaceuticals
Xinhua Pharm
Albert David
Science Direct

Pentavalent Antimonials Market

Pentavalent Antimonials, also called pentavalent antimony compounds, are used to treat patients with leishmaniasis, but they have collateral effects and, in some cases, low cure rate. The compounds currently available for clinical use are: sodium stibogluconate and meglumine antimoniate. Pentavalent antimonials can only be given by injection.
The global Pentavalent Antimonials market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pentavalent Antimonials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pentavalent Antimonials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Pentavalent Antimonials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Pentavalent Antimonials include Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Maiden Pharmaceuticals, Xinhua Pharm, Albert David and Science Direct, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Pentavalent Antimonials, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pentavalent Antimonials, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pentavalent Antimonials, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pentavalent Antimonials sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pentavalent Antimonials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pentavalent Antimonials sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pentavalent Antimonials Market Report

Report Metric Details
Report Name Pentavalent Antimonials Market
Segment by Type
  • Sodium Stibogluconate
  • Meglumine Antimoniate
Segment by Application
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb, Maiden Pharmaceuticals, Xinhua Pharm, Albert David, Science Direct
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Pentavalent Antimonials in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Pentavalent Antimonials manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pentavalent Antimonials sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pentavalent Antimonials Market report?

Ans: The main players in the Pentavalent Antimonials Market are Bristol-Myers Squibb, Maiden Pharmaceuticals, Xinhua Pharm, Albert David, Science Direct

What are the Application segmentation covered in the Pentavalent Antimonials Market report?

Ans: The Applications covered in the Pentavalent Antimonials Market report are Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Pentavalent Antimonials Market report?

Ans: The Types covered in the Pentavalent Antimonials Market report are Sodium Stibogluconate, Meglumine Antimoniate

1 Study Coverage
1.1 Pentavalent Antimonials Product Introduction
1.2 Market by Type
1.2.1 Global Pentavalent Antimonials Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sodium Stibogluconate
1.2.3 Meglumine Antimoniate
1.3 Market by Application
1.3.1 Global Pentavalent Antimonials Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pentavalent Antimonials Sales Estimates and Forecasts 2019-2030
2.2 Global Pentavalent Antimonials Revenue by Region
2.2.1 Global Pentavalent Antimonials Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pentavalent Antimonials Revenue by Region (2019-2024)
2.2.3 Global Pentavalent Antimonials Revenue by Region (2025-2030)
2.2.4 Global Pentavalent Antimonials Revenue Market Share by Region (2019-2030)
2.3 Global Pentavalent Antimonials Sales Estimates and Forecasts 2019-2030
2.4 Global Pentavalent Antimonials Sales by Region
2.4.1 Global Pentavalent Antimonials Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pentavalent Antimonials Sales by Region (2019-2024)
2.4.3 Global Pentavalent Antimonials Sales by Region (2025-2030)
2.4.4 Global Pentavalent Antimonials Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pentavalent Antimonials Sales by Manufacturers
3.1.1 Global Pentavalent Antimonials Sales by Manufacturers (2019-2024)
3.1.2 Global Pentavalent Antimonials Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pentavalent Antimonials in 2023
3.2 Global Pentavalent Antimonials Revenue by Manufacturers
3.2.1 Global Pentavalent Antimonials Revenue by Manufacturers (2019-2024)
3.2.2 Global Pentavalent Antimonials Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pentavalent Antimonials Revenue in 2023
3.3 Global Key Players of Pentavalent Antimonials, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pentavalent Antimonials Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pentavalent Antimonials, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pentavalent Antimonials, Product Offered and Application
3.8 Global Key Manufacturers of Pentavalent Antimonials, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pentavalent Antimonials Sales by Type
4.1.1 Global Pentavalent Antimonials Historical Sales by Type (2019-2024)
4.1.2 Global Pentavalent Antimonials Forecasted Sales by Type (2025-2030)
4.1.3 Global Pentavalent Antimonials Sales Market Share by Type (2019-2030)
4.2 Global Pentavalent Antimonials Revenue by Type
4.2.1 Global Pentavalent Antimonials Historical Revenue by Type (2019-2024)
4.2.2 Global Pentavalent Antimonials Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pentavalent Antimonials Revenue Market Share by Type (2019-2030)
4.3 Global Pentavalent Antimonials Price by Type
4.3.1 Global Pentavalent Antimonials Price by Type (2019-2024)
4.3.2 Global Pentavalent Antimonials Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pentavalent Antimonials Sales by Application
5.1.1 Global Pentavalent Antimonials Historical Sales by Application (2019-2024)
5.1.2 Global Pentavalent Antimonials Forecasted Sales by Application (2025-2030)
5.1.3 Global Pentavalent Antimonials Sales Market Share by Application (2019-2030)
5.2 Global Pentavalent Antimonials Revenue by Application
5.2.1 Global Pentavalent Antimonials Historical Revenue by Application (2019-2024)
5.2.2 Global Pentavalent Antimonials Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pentavalent Antimonials Revenue Market Share by Application (2019-2030)
5.3 Global Pentavalent Antimonials Price by Application
5.3.1 Global Pentavalent Antimonials Price by Application (2019-2024)
5.3.2 Global Pentavalent Antimonials Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pentavalent Antimonials Market Size by Type
6.1.1 US & Canada Pentavalent Antimonials Sales by Type (2019-2030)
6.1.2 US & Canada Pentavalent Antimonials Revenue by Type (2019-2030)
6.2 US & Canada Pentavalent Antimonials Market Size by Application
6.2.1 US & Canada Pentavalent Antimonials Sales by Application (2019-2030)
6.2.2 US & Canada Pentavalent Antimonials Revenue by Application (2019-2030)
6.3 US & Canada Pentavalent Antimonials Market Size by Country
6.3.1 US & Canada Pentavalent Antimonials Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pentavalent Antimonials Sales by Country (2019-2030)
6.3.3 US & Canada Pentavalent Antimonials Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pentavalent Antimonials Market Size by Type
7.1.1 Europe Pentavalent Antimonials Sales by Type (2019-2030)
7.1.2 Europe Pentavalent Antimonials Revenue by Type (2019-2030)
7.2 Europe Pentavalent Antimonials Market Size by Application
7.2.1 Europe Pentavalent Antimonials Sales by Application (2019-2030)
7.2.2 Europe Pentavalent Antimonials Revenue by Application (2019-2030)
7.3 Europe Pentavalent Antimonials Market Size by Country
7.3.1 Europe Pentavalent Antimonials Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pentavalent Antimonials Sales by Country (2019-2030)
7.3.3 Europe Pentavalent Antimonials Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pentavalent Antimonials Market Size
8.1.1 China Pentavalent Antimonials Sales (2019-2030)
8.1.2 China Pentavalent Antimonials Revenue (2019-2030)
8.2 China Pentavalent Antimonials Market Size by Application
8.2.1 China Pentavalent Antimonials Sales by Application (2019-2030)
8.2.2 China Pentavalent Antimonials Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pentavalent Antimonials Market Size by Type
9.1.1 Asia Pentavalent Antimonials Sales by Type (2019-2030)
9.1.2 Asia Pentavalent Antimonials Revenue by Type (2019-2030)
9.2 Asia Pentavalent Antimonials Market Size by Application
9.2.1 Asia Pentavalent Antimonials Sales by Application (2019-2030)
9.2.2 Asia Pentavalent Antimonials Revenue by Application (2019-2030)
9.3 Asia Pentavalent Antimonials Sales by Region
9.3.1 Asia Pentavalent Antimonials Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pentavalent Antimonials Revenue by Region (2019-2030)
9.3.3 Asia Pentavalent Antimonials Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pentavalent Antimonials Market Size by Type
10.1.1 Middle East, Africa and Latin America Pentavalent Antimonials Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pentavalent Antimonials Market Size by Application
10.2.1 Middle East, Africa and Latin America Pentavalent Antimonials Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pentavalent Antimonials Sales by Country
10.3.1 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pentavalent Antimonials Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Sanofi Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GlaxoSmithKline Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bristol-Myers Squibb Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Maiden Pharmaceuticals
11.4.1 Maiden Pharmaceuticals Company Information
11.4.2 Maiden Pharmaceuticals Overview
11.4.3 Maiden Pharmaceuticals Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Maiden Pharmaceuticals Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Maiden Pharmaceuticals Recent Developments
11.5 Xinhua Pharm
11.5.1 Xinhua Pharm Company Information
11.5.2 Xinhua Pharm Overview
11.5.3 Xinhua Pharm Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Xinhua Pharm Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Xinhua Pharm Recent Developments
11.6 Albert David
11.6.1 Albert David Company Information
11.6.2 Albert David Overview
11.6.3 Albert David Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Albert David Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Albert David Recent Developments
11.7 Science Direct
11.7.1 Science Direct Company Information
11.7.2 Science Direct Overview
11.7.3 Science Direct Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Science Direct Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Science Direct Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pentavalent Antimonials Industry Chain Analysis
12.2 Pentavalent Antimonials Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pentavalent Antimonials Production Mode & Process
12.4 Pentavalent Antimonials Sales and Marketing
12.4.1 Pentavalent Antimonials Sales Channels
12.4.2 Pentavalent Antimonials Distributors
12.5 Pentavalent Antimonials Customers
13 Market Dynamics
13.1 Pentavalent Antimonials Industry Trends
13.2 Pentavalent Antimonials Market Drivers
13.3 Pentavalent Antimonials Market Challenges
13.4 Pentavalent Antimonials Market Restraints
14 Key Findings in The Global Pentavalent Antimonials Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Sanofi
GlaxoSmithKline PLC
Bristol–Myers Squibb
Maiden Pharmaceuticals
Xinhua Pharm
Albert David
Science Direct
List of Tables
    Table 1. Global Pentavalent Antimonials Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Sodium Stibogluconate
    Table 3. Major Manufacturers of Meglumine Antimoniate
    Table 4. Global Pentavalent Antimonials Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Pentavalent Antimonials Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Pentavalent Antimonials Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Pentavalent Antimonials Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Pentavalent Antimonials Revenue Market Share by Region (2019-2024)
    Table 9. Global Pentavalent Antimonials Revenue Market Share by Region (2025-2030)
    Table 10. Global Pentavalent Antimonials Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Pentavalent Antimonials Sales by Region (2019-2024) & (g)
    Table 12. Global Pentavalent Antimonials Sales by Region (2025-2030) & (g)
    Table 13. Global Pentavalent Antimonials Sales Market Share by Region (2019-2024)
    Table 14. Global Pentavalent Antimonials Sales Market Share by Region (2025-2030)
    Table 15. Global Pentavalent Antimonials Sales by Manufacturers (2019-2024) & (g)
    Table 16. Global Pentavalent Antimonials Sales Share by Manufacturers (2019-2024)
    Table 17. Global Pentavalent Antimonials Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Pentavalent Antimonials Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Pentavalent Antimonials, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Pentavalent Antimonials Price by Manufacturers 2019-2024 (USD/mg)
    Table 21. Global Pentavalent Antimonials Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Pentavalent Antimonials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pentavalent Antimonials as of 2023)
    Table 23. Global Key Manufacturers of Pentavalent Antimonials, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Pentavalent Antimonials, Product Offered and Application
    Table 25. Global Key Manufacturers of Pentavalent Antimonials, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Pentavalent Antimonials Sales by Type (2019-2024) & (g)
    Table 28. Global Pentavalent Antimonials Sales by Type (2025-2030) & (g)
    Table 29. Global Pentavalent Antimonials Sales Share by Type (2019-2024)
    Table 30. Global Pentavalent Antimonials Sales Share by Type (2025-2030)
    Table 31. Global Pentavalent Antimonials Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Pentavalent Antimonials Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Pentavalent Antimonials Revenue Share by Type (2019-2024)
    Table 34. Global Pentavalent Antimonials Revenue Share by Type (2025-2030)
    Table 35. Pentavalent Antimonials Price by Type (2019-2024) & (USD/mg)
    Table 36. Global Pentavalent Antimonials Price Forecast by Type (2025-2030) & (USD/mg)
    Table 37. Global Pentavalent Antimonials Sales by Application (2019-2024) & (g)
    Table 38. Global Pentavalent Antimonials Sales by Application (2025-2030) & (g)
    Table 39. Global Pentavalent Antimonials Sales Share by Application (2019-2024)
    Table 40. Global Pentavalent Antimonials Sales Share by Application (2025-2030)
    Table 41. Global Pentavalent Antimonials Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Pentavalent Antimonials Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Pentavalent Antimonials Revenue Share by Application (2019-2024)
    Table 44. Global Pentavalent Antimonials Revenue Share by Application (2025-2030)
    Table 45. Pentavalent Antimonials Price by Application (2019-2024) & (USD/mg)
    Table 46. Global Pentavalent Antimonials Price Forecast by Application (2025-2030) & (USD/mg)
    Table 47. US & Canada Pentavalent Antimonials Sales by Type (2019-2024) & (g)
    Table 48. US & Canada Pentavalent Antimonials Sales by Type (2025-2030) & (g)
    Table 49. US & Canada Pentavalent Antimonials Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Pentavalent Antimonials Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Pentavalent Antimonials Sales by Application (2019-2024) & (g)
    Table 52. US & Canada Pentavalent Antimonials Sales by Application (2025-2030) & (g)
    Table 53. US & Canada Pentavalent Antimonials Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Pentavalent Antimonials Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Pentavalent Antimonials Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Pentavalent Antimonials Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Pentavalent Antimonials Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Pentavalent Antimonials Sales by Country (2019-2024) & (g)
    Table 59. US & Canada Pentavalent Antimonials Sales by Country (2025-2030) & (g)
    Table 60. Europe Pentavalent Antimonials Sales by Type (2019-2024) & (g)
    Table 61. Europe Pentavalent Antimonials Sales by Type (2025-2030) & (g)
    Table 62. Europe Pentavalent Antimonials Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Pentavalent Antimonials Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Pentavalent Antimonials Sales by Application (2019-2024) & (g)
    Table 65. Europe Pentavalent Antimonials Sales by Application (2025-2030) & (g)
    Table 66. Europe Pentavalent Antimonials Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Pentavalent Antimonials Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Pentavalent Antimonials Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Pentavalent Antimonials Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Pentavalent Antimonials Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Pentavalent Antimonials Sales by Country (2019-2024) & (g)
    Table 72. Europe Pentavalent Antimonials Sales by Country (2025-2030) & (g)
    Table 73. China Pentavalent Antimonials Sales by Type (2019-2024) & (g)
    Table 74. China Pentavalent Antimonials Sales by Type (2025-2030) & (g)
    Table 75. China Pentavalent Antimonials Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Pentavalent Antimonials Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Pentavalent Antimonials Sales by Application (2019-2024) & (g)
    Table 78. China Pentavalent Antimonials Sales by Application (2025-2030) & (g)
    Table 79. China Pentavalent Antimonials Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Pentavalent Antimonials Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Pentavalent Antimonials Sales by Type (2019-2024) & (g)
    Table 82. Asia Pentavalent Antimonials Sales by Type (2025-2030) & (g)
    Table 83. Asia Pentavalent Antimonials Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Pentavalent Antimonials Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Pentavalent Antimonials Sales by Application (2019-2024) & (g)
    Table 86. Asia Pentavalent Antimonials Sales by Application (2025-2030) & (g)
    Table 87. Asia Pentavalent Antimonials Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Pentavalent Antimonials Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Pentavalent Antimonials Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Pentavalent Antimonials Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Pentavalent Antimonials Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Pentavalent Antimonials Sales by Region (2019-2024) & (g)
    Table 93. Asia Pentavalent Antimonials Sales by Region (2025-2030) & (g)
    Table 94. Middle East, Africa and Latin America Pentavalent Antimonials Sales by Type (2019-2024) & (g)
    Table 95. Middle East, Africa and Latin America Pentavalent Antimonials Sales by Type (2025-2030) & (g)
    Table 96. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Pentavalent Antimonials Sales by Application (2019-2024) & (g)
    Table 99. Middle East, Africa and Latin America Pentavalent Antimonials Sales by Application (2025-2030) & (g)
    Table 100. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Pentavalent Antimonials Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Pentavalent Antimonials Sales by Country (2019-2024) & (g)
    Table 106. Middle East, Africa and Latin America Pentavalent Antimonials Sales by Country (2025-2030) & (g)
    Table 107. Sanofi Company Information
    Table 108. Sanofi Description and Major Businesses
    Table 109. Sanofi Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
    Table 110. Sanofi Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Sanofi Recent Developments
    Table 112. GlaxoSmithKline Company Information
    Table 113. GlaxoSmithKline Description and Major Businesses
    Table 114. GlaxoSmithKline Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
    Table 115. GlaxoSmithKline Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. GlaxoSmithKline Recent Developments
    Table 117. Bristol-Myers Squibb Company Information
    Table 118. Bristol-Myers Squibb Description and Major Businesses
    Table 119. Bristol-Myers Squibb Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
    Table 120. Bristol-Myers Squibb Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Bristol-Myers Squibb Recent Developments
    Table 122. Maiden Pharmaceuticals Company Information
    Table 123. Maiden Pharmaceuticals Description and Major Businesses
    Table 124. Maiden Pharmaceuticals Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
    Table 125. Maiden Pharmaceuticals Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Maiden Pharmaceuticals Recent Developments
    Table 127. Xinhua Pharm Company Information
    Table 128. Xinhua Pharm Description and Major Businesses
    Table 129. Xinhua Pharm Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
    Table 130. Xinhua Pharm Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Xinhua Pharm Recent Developments
    Table 132. Albert David Company Information
    Table 133. Albert David Description and Major Businesses
    Table 134. Albert David Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
    Table 135. Albert David Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Albert David Recent Developments
    Table 137. Science Direct Company Information
    Table 138. Science Direct Description and Major Businesses
    Table 139. Science Direct Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
    Table 140. Science Direct Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Science Direct Recent Developments
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Pentavalent Antimonials Distributors List
    Table 145. Pentavalent Antimonials Customers List
    Table 146. Pentavalent Antimonials Market Trends
    Table 147. Pentavalent Antimonials Market Drivers
    Table 148. Pentavalent Antimonials Market Challenges
    Table 149. Pentavalent Antimonials Market Restraints
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pentavalent Antimonials Product Picture
    Figure 2. Global Pentavalent Antimonials Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pentavalent Antimonials Market Share by Type in 2023 & 2030
    Figure 4. Sodium Stibogluconate Product Picture
    Figure 5. Meglumine Antimoniate Product Picture
    Figure 6. Global Pentavalent Antimonials Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Pentavalent Antimonials Market Share by Application in 2023 & 2030
    Figure 8. Hospitals Pharmacies
    Figure 9. Retail Pharmacies
    Figure 10. Online Pharmacies
    Figure 11. Pentavalent Antimonials Report Years Considered
    Figure 12. Global Pentavalent Antimonials Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Pentavalent Antimonials Revenue 2019-2030 (US$ Million)
    Figure 14. Global Pentavalent Antimonials Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Pentavalent Antimonials Revenue Market Share by Region (2019-2030)
    Figure 16. Global Pentavalent Antimonials Sales 2019-2030 ((g)
    Figure 17. Global Pentavalent Antimonials Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Pentavalent Antimonials Sales YoY (2019-2030) & (g)
    Figure 19. US & Canada Pentavalent Antimonials Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Pentavalent Antimonials Sales YoY (2019-2030) & (g)
    Figure 21. Europe Pentavalent Antimonials Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Pentavalent Antimonials Sales YoY (2019-2030) & (g)
    Figure 23. China Pentavalent Antimonials Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Pentavalent Antimonials Sales YoY (2019-2030) & (g)
    Figure 25. Asia (excluding China) Pentavalent Antimonials Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Pentavalent Antimonials Sales YoY (2019-2030) & (g)
    Figure 27. Middle East, Africa and Latin America Pentavalent Antimonials Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Pentavalent Antimonials Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Pentavalent Antimonials in the World: Market Share by Pentavalent Antimonials Revenue in 2023
    Figure 30. Global Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Pentavalent Antimonials Sales Market Share by Type (2019-2030)
    Figure 32. Global Pentavalent Antimonials Revenue Market Share by Type (2019-2030)
    Figure 33. Global Pentavalent Antimonials Sales Market Share by Application (2019-2030)
    Figure 34. Global Pentavalent Antimonials Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Pentavalent Antimonials Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Pentavalent Antimonials Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Pentavalent Antimonials Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Pentavalent Antimonials Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Pentavalent Antimonials Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Pentavalent Antimonials Sales Share by Country (2019-2030)
    Figure 41. U.S. Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Pentavalent Antimonials Sales Market Share by Type (2019-2030)
    Figure 44. Europe Pentavalent Antimonials Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Pentavalent Antimonials Sales Market Share by Application (2019-2030)
    Figure 46. Europe Pentavalent Antimonials Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Pentavalent Antimonials Revenue Share by Country (2019-2030)
    Figure 48. Europe Pentavalent Antimonials Sales Share by Country (2019-2030)
    Figure 49. Germany Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 50. France Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 54. China Pentavalent Antimonials Sales Market Share by Type (2019-2030)
    Figure 55. China Pentavalent Antimonials Revenue Market Share by Type (2019-2030)
    Figure 56. China Pentavalent Antimonials Sales Market Share by Application (2019-2030)
    Figure 57. China Pentavalent Antimonials Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Pentavalent Antimonials Sales Market Share by Type (2019-2030)
    Figure 59. Asia Pentavalent Antimonials Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Pentavalent Antimonials Sales Market Share by Application (2019-2030)
    Figure 61. Asia Pentavalent Antimonials Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Pentavalent Antimonials Revenue Share by Region (2019-2030)
    Figure 63. Asia Pentavalent Antimonials Sales Share by Region (2019-2030)
    Figure 64. Japan Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 68. India Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Pentavalent Antimonials Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Pentavalent Antimonials Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Pentavalent Antimonials Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Pentavalent Antimonials Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Pentavalent Antimonials Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Pentavalent Antimonials Sales Share by Country (2019-2030)
    Figure 75. Brazil Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Pentavalent Antimonials Revenue (2019-2030) & (US$ Million)
    Figure 80. Pentavalent Antimonials Value Chain
    Figure 81. Pentavalent Antimonials Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Antimony Pentafluoride Market Research Report 2024
Global Benzylpenicillin Potassium for Injection Market Research Report 2024
Global Antimony Pentoxide Market Research Report 2024
Global High Purity Antimony Pentafluoride Market Research Report 2024
Global Electronic Grade Antimony Pentafluoride Market Research Report 2024
Global Antimony Metal Market Research Report 2024
Global Antimony III N Butoxide Market Research Report 2024
Global Antimony Pentoxide Flame Retardant Market Research Report 2024
Global Pentavalent Vaccine Market Research Report 2024
Global Bis 2 2 6 6 Tetramethyl 3 5 Heptanedionato Lead Market Research Report 2024
Global Antimony Ore Market Research Report 2024
Global Pentaerythritol Tetrabenzoate Market Insights Forecast to 2030
Global Dimercaprol Market Research Report 2025
Global 2 4 Diethyl 9H Thioxanthen 9 One Market Research Report 2025
Global Cutaneous Leishmaniasis Drugs Market Insights Forecast to 2030
Global Industrial Grade Ammonium Pentaborate Market Research Report 2024
Antimony Oxide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pentobarbital Sodium Injection Market Research Report 2024
Global Diethylene Triamine Penta Methylene Phosphonic Acid Pentasodium salt Market Research Report 2024
Global Antimony Pentoxide Dry Powder Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions